Profile data is unavailable for this security.
About the company
Novozymes A/S is a Denmark-based biotechnology company engaged in the production and sale of industrial enzymes, microorganisms and biopharmaceutical ingredients. The Company operates in four geographical regions: Europe, Middle East & Africa (including Denmark), North America, Asia Pacific and Latin America. It develops and distributes solutions within the market areas agriculture, bioenergy, food & beverages, household care, leather, pharmaceuticals, forest products, textile and wastewater solutions. Novozymes operates through a range of partnerships with companies, such as Bayer and Syngenta in Agriculture and DSM and Adisseo in Animal Health & Nutrition..
- Revenue in DKK (TTM)17.90bn
- Net income in DKK3.02bn
- Incorporated2000
- Employees6.40k
- LocationNovozymes A/SKrogshoejvej 36BAGSVAERD 2880DenmarkDNK
- Phone+45 44460000
- Fax+45 44469999
- Websitehttps://www.novozymes.com/
More ▼
14.49%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 04 Jul 2024 | 12.12m | 2.92% |
| Norges Bank Investment Managementas of 31 Dec 2023 | 8.85m | 2.13% |
| APG Asset Management NVas of 31 Dec 2023 | 7.59m | 1.83% |
| BlackRock Fund Advisorsas of 04 Jul 2024 | 6.44m | 1.55% |
| Impax Asset Management Ltd.as of 28 Jun 2024 | 5.02m | 1.21% |
| GuardCap Asset Management Ltd.as of 31 May 2024 | 4.94m | 1.19% |
| Handelsbanken Fonder ABas of 30 Jun 2024 | 4.14m | 1.00% |
| MFS International (UK) Ltd.as of 31 May 2024 | 4.03m | 0.97% |
| Baillie Gifford & Co.as of 30 Jun 2024 | 3.66m | 0.88% |
| Pictet Asset Management SAas of 30 Jun 2024 | 3.27m | 0.79% |
More ▼
Data from 31 Dec 2023 - 30 Jun 2024Source: FactSet Research Systems Inc.
